AAPL347.86-0.37 (-0.10%) ▼|ABBV285.28+0.09 (+0.03%) ▲|ABT102.99+0.48 (+0.47%) ▲|ACN247.30-11.44 (-4.42%) ▼|ADBE264.70-5.85 (-2.16%) ▼|AMAT382.35+6.77 (+1.80%) ▲|AMD518.40+10.47 (+2.06%) ▲|AMGN442.41-4.87 (-1.09%) ▼|AMT189.80+8.23 (+4.53%) ▲|AMZN249.56-0.82 (-0.33%) ▼|AVGO325.34+2.10 (+0.65%) ▲|AXP313.32-11.85 (-3.64%) ▼|BA186.84-0.72 (-0.38%) ▼|BAC50.79-0.29 (-0.57%) ▼|BKNG156.79-4.31 (-2.68%) ▼|BLK1,121.03-16.26 (-1.43%) ▼|BMY61.73-1.27 (-2.02%) ▼|BNY145.21-0.12 (-0.08%) ▼|BRK-B544.61-2.36 (-0.43%) ▼|C121.01-1.50 (-1.22%) ▼|CAT689.05-15.00 (-2.13%) ▼|CL94.15-3.24 (-3.33%) ▼|CMCSA22.71-0.14 (-0.59%) ▼|COF201.07-2.36 (-1.16%) ▼|COP152.43+6.80 (+4.67%) ▲|COST1,007.27-10.94 (-1.07%) ▼|CRM245.43-4.86 (-1.94%) ▼|CSCO106.52+1.63 (+1.55%) ▲|CVS93.67-0.81 (-0.86%) ▼|CVX232.96+6.28 (+2.77%) ▲|DE645.04+1.42 (+0.22%) ▲|DHR225.92-3.84 (-1.67%) ▼|DIS112.79-0.34 (-0.30%) ▼|DUK124.61-0.79 (-0.63%) ▼|EMR161.41+1.12 (+0.70%) ▲|FDX298.81-5.11 (-1.68%) ▼|GD348.42-2.38 (-0.68%) ▼|GE286.43-7.11 (-2.42%) ▼|GEV825.86-1.57 (-0.19%) ▼|GILD156.94-0.25 (-0.16%) ▼|GM75.54-1.67 (-2.16%) ▼|GOOG320.45-0.31 (-0.10%) ▼|GOOGL323.61-0.62 (-0.19%) ▼|GS885.04-6.26 (-0.70%) ▼|HD319.01-8.72 (-2.66%) ▼|HON219.15+0.84 (+0.38%) ▲|IBM252.62+0.51 (+0.20%) ▲|INTC87.06+1.57 (+1.84%) ▲|INTU345.79-9.11 (-2.57%) ▼|ISRG456.87+13.02 (+2.93%) ▲|JNJ262.87-4.75 (-1.77%) ▼|JPM332.01-4.53 (-1.35%) ▼|KO93.28-2.07 (-2.17%) ▼|LIN510.41+0.05 (+0.01%) ▲|LLY1,282.45-24.24 (-1.86%) ▼|LMT597.36+7.45 (+1.26%) ▲|LOW198.63-5.75 (-2.81%) ▼|LRCX233.12+2.97 (+1.29%) ▲|MA622.00-11.22 (-1.77%) ▼|MCD247.86-4.77 (-1.89%) ▼|MDLZ63.63-1.56 (-2.39%) ▼|MDT96.12-0.47 (-0.49%) ▼|META645.93-2.92 (-0.45%) ▼|MMM174.02-1.54 (-0.88%) ▼|MO74.96-1.11 (-1.46%) ▼|MRK144.97-2.27 (-1.54%) ▼|MS181.42-2.55 (-1.39%) ▼|MSFT524.63+3.55 (+0.68%) ▲|MU885.55+29.06 (+3.39%) ▲|NEE81.90-0.01 (-0.01%) ▼|NFLX67.02-0.04 (-0.05%) ▼|NKE37.68-0.65 (-1.68%) ▼|NOW156.83-0.17 (-0.11%) ▼|NVDA212.30+0.09 (+0.04%) ▲|ORCL127.44+1.90 (+1.51%) ▲|PEP135.08-3.75 (-2.70%) ▼|PFE30.10-0.33 (-1.07%) ▼|PG161.17-3.34 (-2.03%) ▼|PLTR195.88-0.32 (-0.16%) ▼|PM200.57-1.17 (-0.58%) ▼|QCOM174.86+2.03 (+1.17%) ▲|RTX191.21-3.50 (-1.80%) ▼|SBUX101.04-0.87 (-0.85%) ▼|SCHW90.24-1.20 (-1.31%) ▼|SO93.12-0.70 (-0.75%) ▼|SPG211.38-0.67 (-0.31%) ▼|T21.47-1.28 (-5.61%) ▼|TMO667.19-9.36 (-1.38%) ▼|TMUS150.15-8.64 (-5.44%) ▼|TSLA372.04-2.54 (-0.68%) ▼|TXN285.04+5.54 (+1.98%) ▲|UBER67.84-1.23 (-1.78%) ▼|UNH423.36-1.63 (-0.38%) ▼|UNP293.49-4.60 (-1.54%) ▼|UPS100.67-0.86 (-0.84%) ▼|USB59.61-0.42 (-0.69%) ▼|V408.98-5.36 (-1.29%) ▼|VZ44.57-0.64 (-1.40%) ▼|WFC82.45-0.56 (-0.67%) ▼|WMT119.96-1.16 (-0.96%) ▼|XOM183.02+4.79 (+2.69%) ▲|AAPL347.86-0.37 (-0.10%) ▼|ABBV285.28+0.09 (+0.03%) ▲|ABT102.99+0.48 (+0.47%) ▲|ACN247.30-11.44 (-4.42%) ▼|ADBE264.70-5.85 (-2.16%) ▼|AMAT382.35+6.77 (+1.80%) ▲|AMD518.40+10.47 (+2.06%) ▲|AMGN442.41-4.87 (-1.09%) ▼|AMT189.80+8.23 (+4.53%) ▲|AMZN249.56-0.82 (-0.33%) ▼|AVGO325.34+2.10 (+0.65%) ▲|AXP313.32-11.85 (-3.64%) ▼|BA186.84-0.72 (-0.38%) ▼|BAC50.79-0.29 (-0.57%) ▼|BKNG156.79-4.31 (-2.68%) ▼|BLK1,121.03-16.26 (-1.43%) ▼|BMY61.73-1.27 (-2.02%) ▼|BNY145.21-0.12 (-0.08%) ▼|BRK-B544.61-2.36 (-0.43%) ▼|C121.01-1.50 (-1.22%) ▼|CAT689.05-15.00 (-2.13%) ▼|CL94.15-3.24 (-3.33%) ▼|CMCSA22.71-0.14 (-0.59%) ▼|COF201.07-2.36 (-1.16%) ▼|COP152.43+6.80 (+4.67%) ▲|COST1,007.27-10.94 (-1.07%) ▼|CRM245.43-4.86 (-1.94%) ▼|CSCO106.52+1.63 (+1.55%) ▲|CVS93.67-0.81 (-0.86%) ▼|CVX232.96+6.28 (+2.77%) ▲|DE645.04+1.42 (+0.22%) ▲|DHR225.92-3.84 (-1.67%) ▼|DIS112.79-0.34 (-0.30%) ▼|DUK124.61-0.79 (-0.63%) ▼|EMR161.41+1.12 (+0.70%) ▲|FDX298.81-5.11 (-1.68%) ▼|GD348.42-2.38 (-0.68%) ▼|GE286.43-7.11 (-2.42%) ▼|GEV825.86-1.57 (-0.19%) ▼|GILD156.94-0.25 (-0.16%) ▼|GM75.54-1.67 (-2.16%) ▼|GOOG320.45-0.31 (-0.10%) ▼|GOOGL323.61-0.62 (-0.19%) ▼|GS885.04-6.26 (-0.70%) ▼|HD319.01-8.72 (-2.66%) ▼|HON219.15+0.84 (+0.38%) ▲|IBM252.62+0.51 (+0.20%) ▲|INTC87.06+1.57 (+1.84%) ▲|INTU345.79-9.11 (-2.57%) ▼|ISRG456.87+13.02 (+2.93%) ▲|JNJ262.87-4.75 (-1.77%) ▼|JPM332.01-4.53 (-1.35%) ▼|KO93.28-2.07 (-2.17%) ▼|LIN510.41+0.05 (+0.01%) ▲|LLY1,282.45-24.24 (-1.86%) ▼|LMT597.36+7.45 (+1.26%) ▲|LOW198.63-5.75 (-2.81%) ▼|LRCX233.12+2.97 (+1.29%) ▲|MA622.00-11.22 (-1.77%) ▼|MCD247.86-4.77 (-1.89%) ▼|MDLZ63.63-1.56 (-2.39%) ▼|MDT96.12-0.47 (-0.49%) ▼|META645.93-2.92 (-0.45%) ▼|MMM174.02-1.54 (-0.88%) ▼|MO74.96-1.11 (-1.46%) ▼|MRK144.97-2.27 (-1.54%) ▼|MS181.42-2.55 (-1.39%) ▼|MSFT524.63+3.55 (+0.68%) ▲|MU885.55+29.06 (+3.39%) ▲|NEE81.90-0.01 (-0.01%) ▼|NFLX67.02-0.04 (-0.05%) ▼|NKE37.68-0.65 (-1.68%) ▼|NOW156.83-0.17 (-0.11%) ▼|NVDA212.30+0.09 (+0.04%) ▲|ORCL127.44+1.90 (+1.51%) ▲|PEP135.08-3.75 (-2.70%) ▼|PFE30.10-0.33 (-1.07%) ▼|PG161.17-3.34 (-2.03%) ▼|PLTR195.88-0.32 (-0.16%) ▼|PM200.57-1.17 (-0.58%) ▼|QCOM174.86+2.03 (+1.17%) ▲|RTX191.21-3.50 (-1.80%) ▼|SBUX101.04-0.87 (-0.85%) ▼|SCHW90.24-1.20 (-1.31%) ▼|SO93.12-0.70 (-0.75%) ▼|SPG211.38-0.67 (-0.31%) ▼|T21.47-1.28 (-5.61%) ▼|TMO667.19-9.36 (-1.38%) ▼|TMUS150.15-8.64 (-5.44%) ▼|TSLA372.04-2.54 (-0.68%) ▼|TXN285.04+5.54 (+1.98%) ▲|UBER67.84-1.23 (-1.78%) ▼|UNH423.36-1.63 (-0.38%) ▼|UNP293.49-4.60 (-1.54%) ▼|UPS100.67-0.86 (-0.84%) ▼|USB59.61-0.42 (-0.69%) ▼|V408.98-5.36 (-1.29%) ▼|VZ44.57-0.64 (-1.40%) ▼|WFC82.45-0.56 (-0.67%) ▼|WMT119.96-1.16 (-0.96%) ▼|XOM183.02+4.79 (+2.69%) ▲|
13.2 C
New York
Friday, October 23, 2026

Tag: healthcare

newsFORsourcecompanycontentinformation1releasesmarket

Avista Corp. Reports Financial Results for the Second Quarter of 2025, Confirms 2025 Earnings Guidance with Strong Utility Offsetting Investment Losses

SPOKANE, Wash., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Avista Corp. (NYSE: AVA) today announced financial results for the second quarter of 2025. Net income and earnings per diluted share for the second quarter and year-to-date 2025 compared to the same periods in 2024 are presented in the table below (dollars in millions, except per-share data):

Fortrea Reports Second Quarter 2025 Results

For the three months ended June 30, 2025, from continuing operations:

Everhope Oncology Launches First Cancer Daycare Centre in Gurugram — Revolutionizing Cancer Care with Compassion, Precision and Convenience

Everhope Oncology takes the anxiety out of cancer treatment — with zero wait time, 2X faster service, pre-booked diagnostics, and personalised concierge-led assistance. GURUGRAM, India,...

Forte Medical National Survey Announcement

UK MedTech company launches patient experience survey around overlooked & unreliable Urinary Tract Infection and prenatal screening diagnostics.

Novo Nordisk’s sales increased by 16% in Danish kroner and by 18% at constant exchange rates to DKK 154.9 billion in the first six...

Bagsværd, Denmark, 6 August 2025 - Financial report for the period 1 January 2025 to 30 June 2025                                                                                                                                                            

ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors

EINDHOVEN, The Netherlands, Aug. 06, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces the appointment of Lucas Buchanan as a non-executive member of its Board of Directors.

Everest Medicines Announces Full Approval of NEFECON® in Taiwan

SHANGHAI, Aug. 6, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing,...

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.

Sanofi completes the acquisition of Vigil Neuroscience, Inc.

WuXi AppTec Named Constituent of the FTSE4Good Index Series for Third Consecutive Year

SHANGHAI, Aug. 5, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies...

Bracco Imaging Receives Regulatory Approval in China for SonoVue® in the Assessment of Fallopian Tube Patency

New indication of SonoVue® supports non-invasive assessment of female infertility through contrast-enhanced ultrasound in China MILAN, Aug. 5, 2025 /PRNewswire/ -- Bracco Imaging, a global...

Respiree Secures Second FDA 510(k) Clearance, Expands Cardio-Respiratory Wearable to Home Use via 1Bio™ Connected Care Platform

HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced it has received its second U.S. Food and Drug Administration (FDA) 510(k) clearance. The clearance expands the use of its RS001 cardio-respiratory wearable to home environments and includes approval for its connected care platform marketed as 1Bio™.

New revolutionary brain tech platform ‘ScreenIT’ puts smarter concussion care in reach

SYDNEY, Aug. 6, 2025 /PRNewswire/ -- A revolutionary new brain health assessment platform, ScreenIT, has officially launched, marking a major step forward in how...

Vitiligo Market to Register Incremental Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight

The vitiligo market is witnessing steady growth due to rising disease awareness, improved diagnostic capabilities, and advancements in treatment options such as JAK inhibitors...

TYK2 Inhibitors Market to Drive Enormous Growth by 2034 Due to Strong Pipeline and Expanding Indications | DelveInsight

The TYK2 inhibitor market is expected to witness substantial growth in the coming years, driven by the increasing prevalence of autoimmune diseases, robust clinical...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsHealthcare

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers